Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
UNII: | AAN7QOV9EA |
InChI Key | JAZBEHYOTPTENJ-JLNKQSITSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H30O2 |
Molecular Weight | 302.46 |
AlogP | 5.99 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 13.0 |
Polar Surface Area | 37.3 |
Molecular species | ACID |
Aromatic Rings | 0.0 |
Heavy Atoms | 22.0 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
Hypertriglyceridemia | 3 | D015228 | ClinicalTrials |
Coronary Disease | 3 | D003327 | ClinicalTrials |
Adenomatous Polyposis Coli | 3 | D011125 | ClinicalTrials |
Heart Failure | 3 | D006333 | ClinicalTrials |
Depressive Disorder, Major | 3 | D003865 | ClinicalTrials |
Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Cholestasis | 3 | D002779 | ClinicalTrials |
Obesity | 3 | D009765 | ClinicalTrials |
Intestinal Diseases | 3 | D007410 | ClinicalTrials |
Cachexia | 3 | D002100 | ClinicalTrials |
Glomerulonephritis, IGA | 3 | D005922 | ClinicalTrials |
Anorexia | 3 | D000855 | ClinicalTrials |
Psychotic Disorders | 2 | D011618 | ClinicalTrials |
Breast Neoplasms, Male | 2 | D018567 | ClinicalTrials |
Phobia, Social | 2 | D000072861 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Fatty Liver | 2 | D005234 | ClinicalTrials |
Inflammation | 2 | D007249 | ClinicalTrials |
Carcinoma, Lobular | 2 | D018275 | ClinicalTrials |
Carcinoma, Intraductal, Noninfiltrating | 2 | D002285 | ClinicalTrials |
Lymphoma, Follicular | 2 | D008224 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Bipolar Disorder | 2 | D001714 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Epilepsy | 2 | D004827 | ClinicalTrials |
Liver Diseases | 2 | D008107 | ClinicalTrials |
Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
Substance-Related Disorders | 2 | D019966 | ClinicalTrials |
Hepatitis C, Chronic | 2 | D019698 | ClinicalTrials |
Adenoma | 2 | D000236 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Brain Concussion | 2 | D001924 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Feeding and Eating Disorders | 1 | D001068 | ClinicalTrials |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
Aging | 1 | D000375 | ClinicalTrials |
Leukemia | 1 | D007938 | ClinicalTrials |
Kidney Diseases | 0 | D007674 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 28364 |
ChEMBL | CHEMBL460026 |
DrugBank | DB00159 |
DrugCentral | 3174 |
EPA CompTox | DTXSID9041023 |
FDA SRS | AAN7QOV9EA |
Human Metabolome Database | HMDB0001999 |
Guide to Pharmacology | 3362 |
KEGG | C06428 |
PDB | EPA |
PharmGKB | PA164746077 |
SureChEMBL | SCHEMBL20469 |
ZINC | ZINC000004474603 |